肉毒毒素治疗后皮质兴奋性与帕金森震颤变化
本研究对12例未用药和7例优化左旋多巴治疗的震颤优势型帕金森病患者进行4次肉毒毒素A治疗,采用配对脉冲经颅磁刺激评估皮质兴奋性。结果发现治疗侧基线SICI、LICI和SAI降低,治疗后ICF降低而LICI、SAI、LAI升高,且震颤严重度变化与SICI、LICI、LAI变化相关,提示早期PD震颤与皮质抑制受损及感觉运动整合缺陷有关。
要点
- 早期帕金森病震颤侧皮质抑制和感觉运动整合功能受损。
- 肉毒毒素A治疗可调节皮质兴奋性并改善震颤严重度。
- 震颤变化与SICI、LICI和LAI等指标变化显著相关。
核心结论
- 早期帕金森病震颤严重度可能与皮质内抑制受损和感觉运动整合缺陷相关。
研究设计与样本
- 纳入12例未用药和7例优化左旋多巴治疗的震颤优势型帕金森病患者,每12周接受1次肉毒毒素A治疗共4次,42周内8次访视,采用配对脉冲经颅磁刺激评估皮质兴奋性。
主要发现
- 未用药组治疗侧基线SICI、LICI和SAI较非震颤侧降低(MEP比值更高)。
- 未用药组治疗侧在肉毒毒素A峰值效应时ICF显著降低,LICI、SAI和LAI升高(MEP比值更低)。
- 震颤严重度变化与SICI、LICI和LAI变化显著相关。
临床怎么用
- 配对脉冲经颅磁刺激指标或可用于监测早期帕金森病震颤的皮质兴奋性变化及肉毒毒素A疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To investigate the relationship between botulinum toxin type A (BoNT-A) administration, tremor amplitude, and modulation of intracortical excitability and sensorimotor processing using paired-pulse transcranial magnetic stimulation (pp-TMS) in patients with early, tremor-dominant Parkinson disease (PD). METHODS: Twelve de novo (naive to anti-PD medications) and 7 l-dopa (optimized on levodopa) participants with PD with tremor affecting one arm were recruited. All participants received 4 serial BoNT-A treatments for tremor every 12 weeks and peak effect was assessed 6 weeks posttreatment, totaling 8 visits over 42 weeks. Injection measures were based on kinematic tremor analysis. Short interval intracortical inhibition (SICI), intracortical facilitation (ICF), long interval intracortical inhibition (LICI), and measures of sensorimotor interaction (short-latency afferent [SAI] and long-latency afferent [LAI] stimulation) were assessed in both hemispheres using pp-TMS paradigms at each time point. Linear mixed models analyzed the effect of each pp-TMS measure and tremor severity within each cohort and the association between pp-TMS and tremor severity in the de novo cohort over 42 weeks. t Tests compared pp-TMS measures between hemispheres per time point. RESULTS: Baseline SICI, LICI, and SAI was reduced (higher motor evoked potential [MEP] ratio) on the tremulous/treated side compared to the nontremulous side in de novo participants. On the treated side in the de novo cohort, BoNT-A treatment significantly reduced ICF and increased LICI, SAI, and LAI (lower MEP ratio) at peak BoNT-A time points. The change in tremor severity was significantly associated with changes in SICI, LICI, and LAI. DISCUSSION: Our findings suggest that tremor severity in early PD may be related to impaired intracortical inhibition and defective sensorimotor integration.
引用
- Samotus O, Chen R, Jog M, et al. Changes in Cortical Excitability and Parkinson Tremor After Botulinum Toxin Therapy. Neurology. 2021. PMID: 34497068. doi:10.1212/WNL.0000000000012662
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。